ADMA Biologics, Inc. (ADMA) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate ADMA Biologics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
29.42
Moderate
WeakModerateStrong
P/B Ratio
9.11
Weak
WeakModerateStrong
Earnings Yield
3.38%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
30.78%
Strong
WeakModerateStrong
Operating Margin
37.53%
Strong
WeakModerateStrong
Net Profit Margin
28.80%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
19.63%
Strong
WeakModerateStrong
Net Income Growth
-25.67%
Weak
WeakModerateStrong
EPS Growth
-27.06%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
6.71
Strong
WeakModerateStrong
Quick Ratio
3.74
Strong
WeakModerateStrong
Asset Turnover
0.82x
Moderate
WeakModerateStrong
Inventory Turnover
1.05x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.64%
Weak
WeakModerateStrong
EV / Free Cash Flow
155.96x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.04x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.954
Strong
WeakModerateStrong
Return on Invested Capital
27.57%
Strong
WeakModerateStrong
Cash Conversion Cycle
422.17 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ADMA.
View Financial Statements